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Abstract
Background:  Primary  intestinal  lymphangiectasia  is  a  rare  congenital  disease  described  by  Wald-
mann in  1961  that  is  a  consequence  of  obstruction  of  the  lymphatic  drainage  of  the  small
bowel with  secondary  lymph  vessel  dilation.  This  distorts  the  architecture  of  the  villi  and
causes a  leakage  of  lymph  into  the  intestinal  lumen,  resulting  in  protein-losing  enteropathy
and malabsorption.
Aim:  To  describe  the  clinical,  biochemical,  radiologic,  endoscopic,  and  histologic  characteris-
tics in  children  with  primary  intestinal  lymphangiectasia.
Method:  A  retrospective  observational,  descriptive,  cross-sectional  study  was  conducted  that
reviewed the  case  records  of  children  diagnosed  with  primary  intestinal  lymphangiectasia  that
were seen  at  the  Department  of  Gastroenterology  and  Nutrition  of  the  Instituto  Nacional  de
Pediatría  within  the  time  frame  of  January  1,  1992  to  September  30,  2012.
Results: Four  patients  were  found  that  presented  with  primary  intestinal  lymphangiectasia.
Three of  them  had  been  diagnosed  before  3  years  of  age.  All  the  patients  presented  with  chronic
diarrhea, edema,  lymphopenia,  hypocalcemia,  and  hypogammaglobulinemia,  and  3  patients
presented  with  hypocholesterolemia.  Bowel  transit  time,  endoscopy,  and  intestinal  biopsies
were characteristic  of  this  pathology.
Conclusions:  Intestinal  lymphangiectasia  should  be  suspected  when  there  is  a  clinical  picture  of
chronic diarrhea  and  protein-losing  enteropathy  accompanied  with  edema  at  any  level,  as  well
as hypoalbuminemia,  hypocalcemia,  lymphopenia,  hypogammaglobulinemia,  and  hypocholes-
terolemia,  which  are  the  main  biochemical  ﬁndings  of  this  pathology.  All  children  presenting
with intestinal  lymphangiectasia  should  undergo  an  upper  gastrointestinal  series  with  bowel
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transit  time  and  endoscopy  with  biopsies  taken  at  the  level  of  the  duodenum.  Treatment
includes diet  and  the  periodic  administration  of  albumin  and  gamma  globulin.
© 2013  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.  All
rights reserved.
PALABRAS  CLAVE
Linfangiectasia
intestinal  primaria;
Uso  de
gammaglobulina
Linfangiectasia  intestinal  primaria:  20  an˜os  de  experiencia  en  el  Instituto  Nacional
de  Pediatría
Resumen
Antecedentes:  La  linfangiectasia  intestinal  primaria  es  una  enfermedad  congénita  rara  descrita
por Waldmann  en  1961,  y  que  es  consecuencia  de  una  obstrucción  del  drenaje  linfático  del
intestino delgado  con  dilatación  secundaria  de  los  vasos  linfáticos,  que  distorsionan  la  arqui-
tectura de  las  vellosidades  ocasionando  pérdida  de  linfa  hacia  la  luz  intestinal,dando  como
resultado una  enteropatía  perdedora  de  proteínas  y  malabsorción  de  nutrimentos.
Objetivo:  Describir  las  características  clínicas,  bioquímicas,  radiológicas,  endoscópicas  e  his-
tológicas en  nin˜os  con  linfangiectasia  intestinal  primaria.
Método:  Estudio  observacional,  descriptivo,  transversal  y  retrospectivo  de  nin˜os  con  linfang-
iectasia intestinal  primaria  que  fueron  vistos  en  el  Servicio  de  Gastroenterología  y  Nutrición  del
Instituto Nacional  de  Pediatría  desde  el  1  de  enero  de  1992  al  30  de  septiembre  de  2012,  en
donde se  revisaron  los  expedientes  clínicos  de  los  nin˜os  con  este  diagnóstico.
Resultados:  Se  encontraron  4  pacientes  con  linfangiectasia  intestinal  primaria,  3  de  ellos  diag-
nosticados antes  de  los  3  an˜os;  todos  se  presentaron  con  diarrea  crónica,  edema,  linfopenia,
hipocalcemia,  hipoalbuminemia  e  hipogammaglobulinemia,  y  en  3  pacientes,  con  hipocoles-
terolemia,  y  con  tránsito  intestinal,  endoscopia  y  biopsias  intestinales  características  de  esta
enfermedad.
Conclusiones:  La  linfangiectasia  intestinal  debe  sospecharse  ante  un  cuadro  de  diarrea  crónica,
enteropatía  perdedora  de  proteínas,  que  se  acompan˜a  de  edema  a  cualquier  nivel,  así  como
hipoalbuminemia,  hipocalcemia,  linfopenia,  hipogammaglobulinemia  e  hipocolesterolemia
como los  principales  hallazgos  bioquímicos  de  esta  entidad.  Ante  esta  enfermedad  debe
realizarse  estudio  de  serie  esofagogastroduodenal  con  tránsito  intestinal  y  endoscopia  con  toma
de biopsias  a  nivel  de  duodeno.  El  tratamiento  incluye  dieta  y  administración  periódica  de
albúmina y  gammaglobulina.
© 2013  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
os.
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ntestinal  lymphangiectasia  (IL)  is  a  cause  of  chronic  diar-
hea.  It  is  a  protein-losing  enteropathy  that  can  have  a
rimary  (PIL)  or  secondary  presentation.1,2
PIL  is  a  rare  congenital  disease  that  was  ﬁrst  described  by
aldmann  in  1961  and  is  caused  by  obstruction  of  the  lym-
hatic  draining  of  the  small  bowel  with  a  secondary  dilation
f  the  mucosal,  submucosal,  and/or  serous  lymphatic  vessels
hat  distorts  the  architecture  of  the  villi,3 causing  a  leakage
f  lymph  into  the  intestinal  lumen  that  results  in  nutrient
alabsorption.  The  loss  of  lymph  produces  hypoproteine-
ia,  hypoalbuminemia,  and  lymphopenia,4,5 which  in  turn
an  lead  to  peripheral  edema  (inferior  members),  ascites,
leural  effusion,  weight  loss,  and  delayed  growth  as  typical
linical  manifestations.6 PIL  is  a  congenital  disorder  of  the
ymphatic  system  that  is  usually  diagnosed  before  3  years
f  age4,7,8 and  is  a  typical  example  of  secondary  immu-
odeﬁciency.  Laboratory  ﬁndings  include  hypoproteinemia,
ypoalbuminemia,  lymphocytopenia,  hypogammaglobuline-
ia,  and  reduced  levels  of  transferrin  and  ﬁbrinogen.6,9,10
iagnosis  is  conﬁrmed  by  radiologic,  endoscopic,  and  histo-
ogic  ﬁndings  of  the  dilated  lymph  ducts  and  the  deformity
t
s
n
tf  the  intestinal  villi.11 In  general,  intestinal  lymphangiec-
asia  treatment  can  be  divided  into:  a)  nutritional  support,
)  medication  use,  and  in  some  cases,  c)  surgery.1
The  aim  of  this  study  was  to  know  the  clinical,  biochem-
cal,  radiologic,  and  endoscopic  characteristics  of  children
ith  PIL.
ethods
n  observational,  descriptive,  cross-sectional,  and  retrolec-
ive  study  was  conducted  on  children  diagnosed  with  PIL
hat  were  seen  at  the  Gastroenterology  and  Nutrition  Service
f  the  Instituto  Nacional  de  Pediatría  of  the  Department  of
ealth  within  the  time  frame  of  January  1,  1992  to  Septem-
er  30,  2012.  A  complete  medical  history  was  taken  for
ach  patient,  but  for  the  purposes  of  this  study  only  the
ollowing  variables  were  included:  age  at  the  time  of  diag-
osis,  sex,  and  clinical  manifestations.  The  laboratory  tests
eviewed  were  total  lymphocyte  count,  albumin,  choles-
erol,  serum  calcium,  and  immunoglobulins;  the  specialized
tudies  taken  into  account  were  the  esophagogastroduode-
al  transit  series  and  endoscopic  and  histologic  ﬁndings.  The
reatment  review  included  a)  type  of  diet,  and  b)  whether
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Table  1  Clinical  characteristics  of  the  patients  with  primary  intestinal  lymphangiectasia.
Patient  Sex  Age  at  time
of  diagnosis
Length  of  time
of  progression
Extraintestinal
lymphatic
malformation
Edemas/pleural
effusion/ascites
Height  at  time
of  diagnosis,
cm
Present
height,  cm
1  Female  2  years  14  years  Yes  Yes  81  147.4
2 Female  9  months  16  years  and
6  months
Yes  Yes  68  145
3 Female  3  years  and
3 months
6  years  and
6 months
No  Yes  87  121
4 Male  1  year  and
3 months
5  months  No  Yes  75  75
Table  2  Biochemical  characteristics  of  the  patients  with  primary  intestinal  lymphangiectasia.
Patient  Albumin,
g/dl
Calcium,
mg/dl
IgA,
mg/dl
IgG,
mg/dl
IgM,
mg/dl
Lymphocytes,
uL
Cholesterol,
mg/dl
Triglycerides,
mg/dl
1  1.6  7.3  23.6  156  24.2  600  55  56
2 1.8  7.9  24  132  67.1  1,800  105  52
3 1.4  5.7  74.8  205  42.5  150  94  53
2
o
t
v
6
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Discussion
The  incidence  of  PIL  is  low.  At  the  Instituto  Nacional  de
Pediatría,  a  national  hospital  referral  center,  we  found  only
Table  4  Endoscopic  and  histologic  ﬁndings  in  the  patients
with  primary  intestinal  lymphangiectasia.
Patient  Endoscopy  Histology
1  Increase  in  the
duodenal  folds  and
Lymph  vessel
dilation.  Left  inguinal4 1.8  5.6  27  71.3  
or  not  albumin  and/or  gamma  globulin  were  used,  and
c)  clinical  progression.
The  variables  were  analyzed  using  the  SPSS® version  16.0
program  and  the  result  database  was  registered  therein.
Descriptive  statistics  were  employed.  Frequencies  were
used  for  the  categorical  variables  and  measures  of  cen-
tral  tendency  and  dispersion  were  used  for  the  quantitative
variables.
Results
Four  patients  were  found  to  have  PIL,  and  3  of  them
were  female.  The  mean  age  at  the  time  of  diagnosis  was
22  months  (range  9-39  months).  The  clinical  manifestations
are  shown  in  Table  1,  the  biochemical  ﬁndings  in  Table  2,
and  the  radiologic,  endoscopic  and  histologic  ﬁndings  in
Tables  3  and  4,  respectively.Dietary  and  pharmacologic  treatment  was  used  in  all  of
the  patients;  all  of  the  patients  received  a  protein-rich  and
low-fat  diet  with  a  liposoluble  vitamin  supplement,  calcium,
and  half-chain  triglycerides.4,12,13 Drug  treatment  was  based
Table  3  Radiologic  characteristics  of  the  patients  with  pri-
mary  intestinal  lymphangiectasia.
1  Spiculated  pattern,  data  suggestive  of  inﬂammatory
process  in  the  duodenal  mucosa  and  ileal  jejunum
2 Thick  connivent  folds  in  the  entire  small  bowel,
thickening  of  the  duodenal  mucosa.  Double-rail
images
3 Thickening  of  the  folds  at  the  jejunal  level
and  spiculated  edges,  «stack  of  coins» image
4 Thickened  folds  in  the  small  bowel  with  spiculated
edges  and  some  «stack  of  coins» images1.9  728  110  88
n  diuretics  such  as  furosemide  and/or  spironolactone  at
he  recommended  doses.  Albumin  was  administered  intra-
enously  at  1  g/kg/day  for  5  days  and  gamma  globulin  at
00  mg/kg/day.  These  last  2  drugs  were  administered  every
1-28  days  in  a  continuous  manner.whitish  matter  that
could  be  lymph
lymph  node  with
fusiform-cell
lymphangioma
2 Second  portion  of  the
duodenum  with
abundant  whitish
spots  along  its  entire
course
Vascular  dilations
corresponding  to
lymphangiectasia
3 White  frost  images  Lymphangiectasia.
Moderate  chronic
duodenitis  with
moderate  atrophy
of  the  villi
4 Snowﬂake  images
in  the  duodenum
Lymph  vessel  dilation
corresponding
to intestinal
lymphangiectasia
1 D.  Valdovinos-Oregón  et  al.
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diagnosis  (Table  4).22
The  dietary  treatment  was  based  on  a  high-protein,  low-
fat  diet  with  medium-chain  triglycerides  and  liposoluble0  
 cases  over  a  20-year  period  (1992-2012).  Three  of  them
ere  females,  in  contrast  to  the  male  predominance
eported  in  the  international  literature  in  relation  to  sex.
owever,  our  case  series  was  small,  and  most  likely  a larger
umber  of  cases  is  needed  in  order  to  establish  prevalence
n  relation  to  sex.  According  to  different  reports  in  the
iterature,  PIL  is  diagnosed  before  the  age  of  3  years.2,4,7,8
n  our  case  series,  the  mean  age  at  the  time  of  diagnosis
as  22  months,  coinciding  with  that  published  by  other
uthors  in  which  the  majority  of  PIL  cases  were  diagnosed  in
atients  under  the  age  of  3  years.  Only  one  of  our  patients
as  diagnosed  after  3  years  of  age,  being  a  late  referral.
evertheless,  there  are  also  reports  in  the  literature  of
iagnoses  after  the  age  of  3,  such  as  the  study  published  by
uresh  et  al.  in  2008.14
In  all  the  cases,  the  clinical  manifestations  were  charac-
erized  by  diarrhea,  edema  of  the  extremities,  and  ascites;
 of  the  patients  presented  with  severe  sepsis.  As  is
nown,  edema  and  ascites  present  in  PIL  due  to  its  being
 protein-losing  enteropathy,4,15 and  it  can  often  be  asso-
iated  with  other  extraintestinal  lymphatic  anomalies  such
s  lymphangiomas,16,17 present  in  the  same  2  cases  of  ours
hat  had  asymmetric  lymphedema  of  the  extremities  with  no
ther  clinical  manifestations  consistent  with  syndromic  dis-
ases.  The  increased  pressure  in  the  lymph  vessels  causes
ymph  extravasation  with  an  accumulation  of  chylomicron-
ich  ﬂuid  in  the  peritoneal  cavity;18 this  explains  the  ascites
hat  all  the  patients  presented  with.  Severe  malnutrition  is
 consequence  of  nutrient  malabsorption,  chronic  diarrhea,
nd  protein-losing  enteropathy.  An  important  characteristic
s  that  the  height  of  all  of  our  patients  was  below  normal
arameters,  a  situation  that  continues  up  to  the  present,
aking  under-height  a  constant  ﬁnding  in  PIL1 that  persists
espite  medical  treatment.
Hypoalbuminemia,  hypocalcemia,  lymphocytopenia,  and
ypogammaglobulinemia  were  ﬁndings  in  all  of  our  patients,
hereas  hypocholesterolemia  was  only  observed  in  3  of
hem  (Table  2).
Immunoglobulin  concentrations  are  reduced  in  PIL  and
ellular  immunity  is  also  affected  by  the  lymphocytope-
ia,  resulting  in  secondary  immunodeﬁciency.  Nevertheless,
he  children  in  our  case  series  presented  with  few
evere  infections,  which  is  probably  explained  by  the
act  that  our  treatment  included  periodic  gamma  globulin
dministration.12,19
In  an  article  published  in  2010,  Wen  et  al.  reviewed
eports  in  the  international  literature  spanning  the  time
rame  of  1995  to  2009,  and  found  80  cases,  adding  4
iagnosed  at  their  hospital  center,  in  which  the  female
ex,  together  with  edema  as  a  clinical  characteristic,
redominated  in  78%  of  the  patients;  this  concurs  with  the
esults  of  our  study.  They  reported  a  mean  age  at  the  time
f  diagnosis  of  13.3  years,  including  children  and  adults.  In
hat  study  is  was  striking  that  there  was  a  constant  elevation
f  IgE  in  the  4  patients  described  and  lymphopenia  in  only  2
f  them,  in  contrast  with  our  study,  and  the  presence  of
ymphoma  in  5%  of  the  cases,  manifested  as  abdominal  pain
f  rapid  onset.20The  imaging  studies  revealed  a  thickening  of  the  mucosa
n  3  of  the  4  patients,  a  «stack  of  coins» image  (2/4),
 spiculated  pattern  (4/4),  and  double-rail  images  (1/4).
hese  present  in  children  with  this  pathology  (ﬁg.  1)
F
tigure  1  Intestinal  transit  showing  the  thickening  of  the  folds
n the  small  bowel  with  spiculated  edges  and  «stack  of  coins»
mage.
nd  our  ﬁndings  were  concordant  with  reports  in  the
iterature  (see  Table  3).21 The  endoscopic  image  in  our
ases  showed  the  typical  aspect  of  white  frost  (4/4)  or
nowﬂakes  in  the  intestinal  villi  (ﬁg.  2).  This  contrasts  with
ther  published  case  series  in  which  the  aspect  is  nodular
Table  4).7 Histologically,  lymph  vessel  dilation  was  observed
ﬁgs.  3  and  4),  corroborating  the  intestinal  lymphangiectasiaigure  2  Gastroduodenal  endoscopy  with  white  frost,  consis-
ent with  intestinal  lymphangiectasia.
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TFigure  3  Photomicrograph  of  the  intestinal  wall  showing
numerous  dilated  lymph  vessels,  with  scant  proteinaceous  mat-
ter in  its  interior  (hematoxylin  and  eosin,  x10).
vitamins.  In  regard  to  the  medications  used,  in  addition
to  albumin  and  gamma  globulin,  diuretics  like  furosemide
and/or  spironolactone  were  necessary.  Considering  all  of
the  above,  the  clinical  progress  of  the  children  was
favorable.18,23
Compared  with  other  case  series,  the  study  by  Xinias
et  al.  published  in  March  2013  presents  2  male  patients  with
clinical  characteristics  very  similar  to  those  of  our  patients.
However,  management  with  albumin  was  used  only  in  the
periods  of  exacerbation.  They  do  not  mention  the  use  of
diuretics  or  gamma  globulin  and  their  patients  progressed
well.24
Other  medical  treatments  have  been  proposed  for  PIL
such  as  the  use  of  octreotide,  tranexamic  acid,  and  some
cytotoxic  drugs,  but  they  are  expensive  and  their  results  are
controversial;  they  have  yet  to  be  used  in  our  hospital  cen-
ter.  In  reference  to  octreotide,  its  use  has  been  suggested  in
treatment-refractory  patients.  However,  there  is  little  expe-
rience  with  this  drug  in  children  and  apparently  good  results
have  only  been  reported  in  adults.25--28 Surgical  treatment
such  as  enterectomy  of  the  affected  intestinal  segment  is
only  indicated  when  the  lesion  is  local  or  segmentary,  with
initially  good  results.  When  the  part  of  the  intestine  that  is
affected  does  not  have  clear  margins  deﬁning  the  lesion,  the
Figure  4  Photomicrograph  of  the  intestinal  biopsy  showing
multiple  dilated  lymph  vessels  adjacent  to  normal-appearing
intestinal  glands  (hematoxylin  and  eosin  x40).
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isk/beneﬁt  of  surgery  must  be  evaluated,  given  that  wide
esections  can  cause  short  bowel  syndrome.4,9,29 There  are
eports  in  the  literature  in  which  labeled  albumin  scintigra-
hy  and  abdominal  tomography  were  used  with  apparently
ood  results  to  delimit  the  affected  segment.30,31 In  our  case
eries  these  studies  were  not  done.  In  relation  to  follow-up
t  is  suggested  to  continue  with  surveillance  and  periodic
heck-ups  of  these  children.19
onclusions
ntestinal  lymphangiectasia  in  children  should  be  suspected
henever  there  are  symptoms  of  chronic  diarrhea  and
rotein-losing  enteropathy  accompanied  with  edema  of
he  inferior  extremities,  even  though  this  can  be  present
t  any  level.  Hypoalbuminemia,  hypogammaglobulinemia,
ypocalcemia,  lymphopenia,  and  hypocholesterolemia  are
he  main  biochemical  ﬁndings  in  this  disease.  An  esopha-
ogastroduodenal  transit  study  and  endoscopy  with  biopsy  at
he  duodenal  level  should  be  done  on  every  child  presenting
ith  this  pathology.
These  children  require  opportune  diagnosis  and  multidis-
iplinary  treatment  by  the  gastroenterologist,  nutritionist,
nd  immunologist,  given  the  fact  that  they  can  present  with
evere  life-threatening  intercurrent  infections  and  should  be
onsidered  as  children  with  secondary  immunodeﬁciencies
nd  managed  as  such.  Their  frequent  hospital  visits  pre-
ispose  them  to  school  absenteeism  and  increased  family
xpense.
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